Atlas Trials

CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma

Clinical trial NCT06834529 · RECRUITING

Trial details

NCT number
NCT06834529
Sponsor
Affiliated Hospital to Academy of Military Medical Sciences
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Relapsed or Refractory B Cell Leukemia and Lymphoma
Start date
2025-01-20
Primary completion
2027-01-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.